Brennan Daniel J. 4
4 · BOSTON SCIENTIFIC CORP · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Brennan Daniel J.
EVP and CFO
Transactions
- Sale
Common Stock
2025-02-18$104.08/sh−2,900$301,818→ 247,248 total - Sale
Common Stock
2025-02-18$104.67/sh−14,630$1,531,366→ 232,618 total - Exercise/Conversion
Common Stock
2025-02-19$24.55/sh+18,533$454,985→ 251,151 total - Exercise/Conversion
Common Stock
2025-02-19$17.26/sh+16,865$291,090→ 268,016 total - Exercise/Conversion
Common Stock
2025-02-19$27.09/sh+15,642$423,742→ 283,658 total - Exercise/Conversion
Common Stock
2025-02-19$40.12/sh+9,483$380,458→ 293,141 total - Sale
Common Stock
2025-02-19$105.24/sh−67,333$7,086,111→ 225,808 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-19−15,642→ 31,285 totalExercise: $27.09Exp: 2028-02-15→ Common Stock (15,642 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-19−9,483→ 37,934 totalExercise: $40.12Exp: 2029-02-21→ Common Stock (9,483 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-19−16,865→ 0 totalExercise: $17.26Exp: 2026-02-22→ Common Stock (16,865 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-19−18,533→ 37,067 totalExercise: $24.55Exp: 2027-02-28→ Common Stock (18,533 underlying)
Footnotes (8)
- [F1]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024.
- [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.35 to $104.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.37 to $105.09, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.46, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
- [F6]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
- [F7]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
- [F8]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.